Csop Hang Seng Tech Index ETF(03033.HK) fell 0.79% to HKD 4.772
Newtimespace News, as of 09:45 on April 30, Csop Hang Seng Tech Index ETF(03033.HK) was quoted at HKD 4.772, down 0.79%. The ETF opened at HKD 4.780, with a high of HKD 4.790 and a low of HKD 4.752. The latest trading volume was 64.3104 million units, with a turnover of HKD 307 million, and a turnover rate of 0.36%. The latest NAV per unit is HKD 4.805, with a premium rate of 0.10%. The asset size is approximately HKD 85.467 billion, and the total issuance is 17.786 billion units.
Csop Hang Seng Tech Index ETF(03033.HK) tracks the Hang Seng Tech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of Hong Kong-listed technology-themed companies. Its selection universe covers Hong Kong-listed companies highly related to the technology theme. The index constituents include leading Chinese tech companies such as Tencent, Alibaba, Meituan, JD.com, and Xiaomi, making it a key benchmark for gauging the performance of Hong Kong's technology stocks.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Ascletis-B (01672.HK): Oral Small-molecule GLP-1 ASC30 Initiates Global Phase III Clinical Trials; First-in-class Triple-target FDC Achieves 15.2% Weight Loss in Preclinical Studies
- WUXI APPTEC(02359.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 11.08 billion, YoY increase of 33.7%
- SH PHARMA(02607.HK): Omeprazole Sodium Bicarbonate for Oral Suspension (I) Approved for Production
- LING YUE SER GP(02165.HK): Unsuccessful Tender for Sichuan Land in Public Bidding; Tender Deposit Fully Refunded
- Jinhai Med Tech (02225.HK): Appoints Ma Chengdong as Chief Marketing Officer to Accelerate Foray into Neurosurgical Endoscopy Sector